New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
08:11 EDTIMGN, HTWR, CRVL, SQNM, MDAS, DSCI, CCRN, HITK, AEZS, AMEDOppenheimer to host a conference
23rd Annual Healthcare Conference is being held in New York on December 12-13 with webcasted presentations to begin on December 13 at 7:45 am; not all presentations may be webcasted. Webcast Link
News For AMED;DSCI;CRVL;AEZS;MDAS;HTWR;HITK;SQNM;IMGN;CCRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
17:06 EDTAMEDAmedisys initiated with a Buy at Mizuho
Subscribe for More Information
07:56 EDTSQNMACOG opinion on NIPT not as bullish as hoped for Sequenom, says William Blair
Subscribe for More Information
07:31 EDTAEZSAeterna Zentaris recruited 500 patients for pivotal Phase 3 ZoptEC study
Subscribe for More Information
June 25, 2015
08:37 EDTDSCIDerma Sciences announces publication in ‘Advances in Wound Care’
Subscribe for More Information
07:37 EDTAEZSAeterna Zentaris selects Ergomed to conduct Phase 3 clinical trial of Macrilen
Aeterna Zentaris announced that it has executed a definitive agreement with Ergomed, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen, a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency.
June 23, 2015
14:25 EDTAMEDAmedisys and Almost Family concerns overblown, says Jefferies
Subscribe for More Information
14:17 EDTAMEDAlmost Family and Amedisys shares defended at Jefferies
10:03 EDTAMEDHigh option volume stocks
Subscribe for More Information
June 19, 2015
16:57 EDTHTWRFDA updates recall for HeartWare VAS
Subscribe for More Information
11:45 EDTCRVLHealthways plummets to 52-week low after cutting FY15 revenue outlook
Subscribe for More Information
10:00 EDTAMEDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aerie Pharmaceuticals (AERI) upgraded to Buy from Hold at Canaccord... Amedisys (AMED) upgraded to Buy from Hold at Jefferies... Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI... Delta Air Lines (DAL) upgraded to Outperform from Peer Perform at Wolfe Research... Deutsche Bank (DB) upgraded to Neutral from Underperform at Exane BNP Paribas... EP Energy (EPE) upgraded on better than expected well economics at SunTrust... Encana (ECA) upgraded to Outperform from Market Perform at BMO Capital... Energy Transfer Partners (ETP) upgraded to Buy at BofA/Merrill... Erickson (EAC) upgraded to Outperform from In-Line at Imperial Capital... Fiserv (FISV) upgraded on growth opportunities, margin outlook at Oppenheimer... IPC Healthcare (IPCM) upgraded to Buy from Hold at Jefferies... Mack-Cali Realty (CLI) upgraded on valuation at Stifel... Micron (MU) upgraded to Buy on sustainable margins and capex at Topeka... NuStar Energy (NS) upgraded to Buy from Neutral at BofA/Merrill... NuStar GP Holdings (NSH) upgraded to Buy from Neutral at BofA/Merrill... Ramco-Gershenson (RPT) upgraded to Outperform from Neutral at Baird... Retail Opportunity (ROIC) upgraded to Outperform from Market Perform at Raymond James... Royal Dutch Shell (RDS.A) upgraded to Outperform from Sector Perform at RBC Capital... Smith & Wesson (SWHC) upgraded to Outperform from Sector Perform at RBC Capital... Sovran Self Storage (SSS) upgraded to Buy from Hold at Cantor... Springleaf (LEAF) upgraded to Outperform from Neutral at Macquarie.
06:41 EDTAMEDAmedisys upgraded to Buy from Hold at Jefferies
Subscribe for More Information
June 18, 2015
10:01 EDTMDASOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:32 EDTAEZSAeterna Zentaris awarded extension for NASDAQ listing compliance
Aeterna Zentaris has received notice from NASDAQ determining that the company is eligible for an additional 180 calendar day period, until December 14 to regain compliance with the minimum $1.00 per share required for continued listing. The company's shares continue to trade on the NASDAQ Capital Market under the symbol AEZS.
07:30 EDTDSCIDerma Sciences says completes non-clinical aclerastide toxicology program
Subscribe for More Information
June 17, 2015
16:20 EDTMDASMedAssets initiated with a Perform at Oppenheimer
Subscribe for More Information
08:08 EDTIMGNImmunoGen says IMGN529 exhibits strong synergy with rituximab in NHL subtypes
Subscribe for More Information
07:35 EDTDSCIDerma Sciences says Medicare coverage reinstated for Medihoney products
Derma Sciences announces that the Centers for Medicare & Medicaid Services has reinstated coverage and assigned a reimbursable code for MEDIHONEY dressings effective immediately. Additionally, the four Medicare Administrative Contractors that handle durable medical equipment issued policy adjustments over the last week. Importantly, the January 22, 2015 policy article, which introduced a new coverage standard and was the basis of the MEDIHONEY products’ coding change from covered to non-covered codes, has been rescinded effective June 12, 2015. An amended policy article, adopted by all four DME MACs and effective October 1, 2015, specifically confirms that coverage of multi-component dressings that contain medicinal honey will be based on the underlying covered components.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use